Cancer Treatment News and Research

RSS

Basic concepts lay the foundation for personalized immunotherapy

Personalized Immunotherapy for Tumor Diseases and Beyond introduces personalized immunotherapy with multi-dimensional models of analysis to determine the best plan for the immunotherapy of patients.

23 Nov 2020

Expert provides new perspective on safe, effective use of cardiac imaging in COVID-19 patients

The cutting edge of cardiovascular imaging: that's the focus of EACVI - Best of Imaging 2020, a scientific congress of the European Society of Cardiology (ESC). A pioneering event covering the full spectrum of cardiac imaging. Explore the scientific program.

19 Nov 2020

Researchers use proteogenomics to better understand the biological complexity of breast cancer

Researchers at Baylor College of Medicine, the Broad Institute of MIT and Harvard and other institutions have applied powerful proteogenomics approaches to better understand the biological complexity of breast cancer.

18 Nov 2020

Negative biopsies during active surveillance for prostate cancer are associated with long-term outcomes

Can early-stage prostate cancer "vanish" during follow-up? More likely the cancer is just "hidden"--either way, negative biopsies during active surveillance for prostate cancer are associated with excellent long-term outcomes, reports a study in The Journal of Urology®.

18 Nov 2020

Targeting BCAP with new drugs could benefit people with inflammatory bowel disease

Managing the activity of the BCAP protein could help the body repair intestinal tissue from damage caused by inflammation, according to a new study led by experts at Cincinnati Children's.

17 Nov 2020

New tool predicts which cancer patients will respond positively to immunotherapy

An international group led by Dr Banafshe Larijani, an Ikerbasque researcher seconded to the Biofisika Institute (UPV/EHU-University of the Basque Country, CSIC), has developed a new diagnostic method making it possible to accurately predict which cancer patients will respond positively to immunotherapy.

16 Nov 2020

New cancer study may result in more effective treatments

For decades, scientists and doctors have been searching for a cure for cancer. Now, researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) have taken a significant step forward with a new concept that could ultimately result in more effective treatments.

15 Nov 2020

PARP inhibitor, stenoparib inhibits pre- and post-entry processes of SARS-CoV-2 in vitro

A team of researchers from the Northern Arizona University evaluated a new PARP inhibitor, stenoparib, which has recently advanced to Stage II of clinical trials to treat ovarian cancer. Their study, an initial report on in vitro stenoparib activity against human coronaviruses such as SARS-CoV-2, has been published on the preprint server bioRxiv*.

15 Nov 2020

Immunotherapy combination shrinks rare angiosarcoma tumors in 25% of patients

Researchers from SWOG Cancer Research Network, a cancer clinical trials group funded by the National Cancer Institute's Division of Cancer Diagnosis and Treatment, part of the National Institutes of Health, have shown that the immunotherapy combination of ipilimumab and nivolumab shrinks rare angiosarcoma tumors in 25 percent of all patients, with some having an even stronger response to the drug combination.

15 Nov 2020

New model can predict the risk of adverse side effects of cancer treatment

The risk of serious adverse effects on the blood status and bone marrow of patients during chemotherapy can be predicted by a model developed at Linköping University, Sweden.

12 Nov 2020

JNCCN: Cost-effectiveness of olaparib for metastatic pancreatic cancer

Studies have shown that utilizing a PARP inhibitor in the management of patients with metastatic pancreatic cancer who harbor BRCA 1/2 mutations is clinically beneficial.

12 Nov 2020

New method using light-activated liposomes is safer, more direct to deliver CRISPR gene therapy

Light-activated liposomes could help to deliver CRISPR gene therapy - and the method could prove safer and more direct than current methods.

12 Nov 2020

Researchers assess the risk of proton therapy for children with brain tumors

Adelaide is poised to open Australia's first proton therapy center in 2025, with children and young adults expected to be the main beneficiaries of more effective cancer treatment with fewer side effects.

12 Nov 2020

A new method to improve the preclinical evaluation of CAR T cell therapies

Ludwig Cancer Research scientists have developed a method to significantly improve the preclinical evaluation of chimeric antigen-receptor (CAR) T cell therapies, in which the immune system's T cells are extracted from a patient, engineered to target a specific tumor-associated molecule and then grown and reinfused for cancer treatment.

6 Nov 2020

Virginia Tech student receives NSERC award to develop minimally invasive treatment for glioblastoma

The Natural Sciences and Engineering Research Council of Canada (NSERC) supports research that results in "breakthrough answers to timeless questions." When choosing awardees, the council looks for creativity and innovation, two qualities they see at the heart of all research advances.

6 Nov 2020

Cancer Treatment News and Research

Basic concepts lay the foundation for personalized immunotherapy

Expert provides new perspective on safe, effective use of cardiac imaging in COVID-19 patients

Researchers use proteogenomics to better understand the biological complexity of breast cancer

Negative biopsies during active surveillance for prostate cancer are associated with long-term outcomes

Targeting BCAP with new drugs could benefit people with inflammatory bowel disease

New tool predicts which cancer patients will respond positively to immunotherapy

New cancer study may result in more effective treatments

PARP inhibitor, stenoparib inhibits pre- and post-entry processes of SARS-CoV-2 in vitro

Immunotherapy combination shrinks rare angiosarcoma tumors in 25% of patients

New model can predict the risk of adverse side effects of cancer treatment

JNCCN: Cost-effectiveness of olaparib for metastatic pancreatic cancer

New method using light-activated liposomes is safer, more direct to deliver CRISPR gene therapy

Researchers assess the risk of proton therapy for children with brain tumors

A new method to improve the preclinical evaluation of CAR T cell therapies

Virginia Tech student receives NSERC award to develop minimally invasive treatment for glioblastoma

Unrelated mutations can lead to false-positive results in men with advanced prostate cancer

Two studies find age as a primary factor in melanoma treatment resistance

Drug used to control blood pressure may improve cancer patients’ response to immunotherapy

Potential treatment might make tumors more responsive to immunotherapy

High Throughput Identification and Quantification of Breast Cancer With NMR-Based Metabolomics

Your guide to microplate readers for cancer research eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News